$6.9 B

PRAH Mkt cap, 12-Dec-2018

$717.6 M

PRA Health Sciences Revenue Q3, 2018
PRA Health Sciences Gross profit (Q3, 2018)346.2 M
PRA Health Sciences Gross profit margin (Q3, 2018), %48.2%
PRA Health Sciences Net income (Q3, 2018)1.9 M
PRA Health Sciences EBIT (Q3, 2018)38.8 M
PRA Health Sciences Cash, 30-Sep-2018127.5 M
PRA Health Sciences EV7.9 B

PRA Health Sciences Revenue Breakdown

Embed Graph

PRA Health Sciences revenue breakdown by geographic segment: 30.6% from Europe, Africa, and Asia-Pacific and 69.4% from Americas

PRA Health Sciences Income Statement

Annual

USDFY, 2015FY, 2016FY, 2017

Revenue

1.6b1.8b2.3b

Revenue growth, %

12%

General and administrative expense

246.4m269.9m322.0m

Operating expense total

69.7m269.9m322.0m

Depreciation and amortization

78.0m69.5m78.2m

EBIT

164.3m162.3m176.2m

EBIT margin, %

10%9%8%

Interest expense

61.7m54.9m46.7m

Income tax expense

30.0m28.5m(12.6m)

Net Income

81.8m68.2m87.3m

PRA Health Sciences Balance Sheet

Annual

USDFY, 2015FY, 2016FY, 2017

Cash

121.1m144.6m192.2m

Inventories

30.2m35.4m

Current Assets

573.8m624.7m877.0m

PP&E

143.1m

Goodwill

1.0b972.0m1.5b

Total Assets

2.2b2.2b3.4b

Accounts Payable

57.1m51.3m64.6m

Short-term debt

31.3m28.8m

Current Liabilities

530.0m564.2m971.6m

Long-term debt

1.2b

Total Debt

31.3m1.3b

Total Liabilities

1.5b2.4b

Additional Paid-in Capital

828.3m879.1m905.4m

Retained Earnings

6.1m74.3m161.2m

Total Equity

702.7m729.3m936.5m

Debt to Equity Ratio

0 x

Debt to Assets Ratio

0 x

Financial Leverage

3.2 x3 x3.6 x

PRA Health Sciences Cash Flow

Annual

USDFY, 2015FY, 2016FY, 2017

Net Income

(39.9m)68.2m87.3m

Depreciation and Amortization

25.3m69.5m78.2m

Accounts Payable

(46.2m)(1.5m)35.8m

Cash From Operating Activities

35.9m160.0m220.4m

Purchases of PP&E

(4.9m)(33.1m)(61.3m)

Cash From Investing Activities

(1.0b)(34.6m)(687.4m)

Long-term Borrowings

(567.1m)(822.6m)(125.5m)

Cash From Financing Activities

1.1b(101.6m)507.0m

Income Taxes Paid

3.1m7.3m10.6m

PRA Health Sciences Ratios

USDY, 2018

EV/EBIT

204.6 x

EV/CFO

40 x

Debt/Equity

1.2 x

Debt/Assets

0.4 x

Financial Leverage

3.3 x
Report incorrect company information

PRA Health Sciences Employee Rating

3.4752 votes
Culture & Values
3.5
Work/Life Balance
3.5
Senior Management
2.9
Salary & Benefits
3.3
Career Opportunities
3.0
Source